MIF and asthma: Interestingly, recent studies have demonstrated that MIF induces resistance to glucocorticoids in severe neutrophilic asthma, highlighting the potential of targeting MIF as a therapeutic strategy to enhance glucocorticoid responsiveness and alleviate inflammation in severe asthma [213].